Open AccessThe specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease
Author(s) -
Е. Е. Васенина,
О С Левин
Publication year - 2012
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2012-413
Subject(s) - rivastigmine , nucleus basalis , transdermal , cholinergic , medicine , dementia , cholinesterase , disease , adverse effect , cholinergic neuron , pharmacology , donepezil